Israel’s OurCrowd, the world’s leading equity crowdfunding platform, marked Israel’s 67th birthday by announcing its 67th portfolio company. ElMindA (see Sept newsletter) developed the world’s first FDA-approved neural functional assessment tool to visualize serious brain trauma and illnesses.